Anti-CD22 immunoconjugate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD22 immunoconjugate, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate